Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here with good news for biotech startups, a milestone in CRISPR, and an idea for making gene therapy cheaper — both to make and to take.
The need-to-know this morning
• GSK reported third-quarter adjusted earnings of 50.4 pence, exceeding analyst consensus. Sales grew 10% year over year to 8.2 billion pounds, also topping consensus. The company raised guidance for the remainder of the year.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect